August 15, 2016 – Edwards Lifesciences announced the U.S. Food and Drug Administration (FDA) approved of the advanced Edwards Intuity Elite valve system, a rapid deployment device for surgical aortic valve replacement. Built on the Perimount tissue valve platform and incorporating innovations from transcatheter heart valves, the the new valve is designed to facilitate minimally invasive surgery and streamline complex aortic valve replacements, thereby offering a cutting-edge treatment option for patients with aortic valve disease. The device is now commercially available. 

August 12, 2016 — Electrophysiology ablation navigation system company Stereotaxis Inc. announced its shares of common stock started trading on the OTCQX Best Market, effective Aug. 4, after Stereotaxis received a letter from The NASDAQ Stock Market LLC notifying the company Aug. 2 that it would be delisted. The NASDAQ letter stated Stereotaxis continued to be non-compliant with the market value of listed securities requirement, which required that Stereotaxis evidence a minimum market capitalization of $35 million.

August 11, 2016 — Carew Medical Wear Inc., a custom medical outfit company specializing in left ventricular assistance device (LVAD) undergarments, has teamed up with Major League Baseball Hall of Fame inductee Rod Carew in efforts to fill the void in the garment industry that support the Heartmate II LVAD.

August 11, 2016 — Cardiovascular diseases are the leading cause of death in the United States. With one in every four deaths occurring each year, the five-year survival rate after a heart attack is worse than most cancers. A big part of the problem is the inability of the human heart to effectively repair itself after injury. A team of University of Houston (UH) researchers is trying to change that.

August 10, 2016 — Mercator MedSystems Inc. announced the enrollment of the first critical limb ischemia (CLI) patients in the LIMBO-ATX trial, the design of which was approved by the U.S. Food and Drug Administration (FDA) under an Investigation New Drug (IND) application. The study is designed to measure the benefit of localized drug delivery using the company's proprietary Bullfrog Micro-Infusion Device in combination with opening obstructed arteries in the lower leg.

August 10, 2016 — Access Scientific introduced the PowerWand XL, a companion to the PowerWand All-in-One, in July. The Powerwand XL is designed specifically for clinicians who prefer to use a component-based, over-wire insertion technique similar to the Modified Seldinger Technique (MST) they currently use.

The XL technique feels similar to the MST, but XL advantages include:

Scientists have shown that people who exercise for even a few hours each week can enlarge their hearts. This is a normal and beneficial response to exercise, but until now has only been recognized in athletes. The researchers say that doctors should now consider an individual’s activity level before diagnosing common heart conditions.

Cath lab radiation dose, dose reduction, cath lab staff radiation dose
Corindus, corpath, robotic PCI, cath lab robots
raysafe, unifors, radiation dose monitoring, cath lab radiation exposure
CFI, zerogravity, zero gravity, cath lab radiation protection system, TIDI Products

In the past few years, concern has skyrocketed from interventional cardiologists and cath lab staff over radiation dose exposure from the angiographic X-ray imaging systems. This is partly due to accumulation of study data showing the impact of radiation exposure on the job, with interventional cardiologists having higher rates of left-sided brain tumors, skin cancer, posterior subcapsular lens changes (a precursor to cataracts), thyroid disease and neuro-degenerative disease.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now